Cytek Biosciences, Inc
Price
FilingsNewest: 8-K, Charter or bylaws changeSep 29 →InsidersNo open-market buys or sales.→HoldersBlackRock 7.4%Millennium 7.2%Boston Partners 5.9%→PeersClosest companies: TXG, BNGO, QSI→
From the filings
Figures
- Revenue
- $206.7Mlast 12 months
- Net income
- −$80.6Mlast 12 months
- Operating cash flow
- −$7.3Mlast 12 months
- Cash and equivalents
- $73.8Mat the last balance sheet
- Shares outstanding
- 130.0M shareson issue